http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111991372-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c74591a419b389b0c196d3b3bf3caecc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate | 2020-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7e687e33453f93c01e466dc153c4e39 |
| publicationDate | 2020-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111991372-A |
| titleOfInvention | Application of medical skin repair patch in the preparation of dermatitis medicine |
| abstract | The invention belongs to the technical field of biomedicine, and particularly relates to the application of a medical skin repair patch in the preparation of a medicine for treating dermatitis. The present invention proposes for the first time that the medical skin repair patch is used in the clinical treatment of various types of dermatitis, and has an obvious auxiliary treatment effect on the dermatitis. The present invention adopts a multi-center and open experimental design, and takes facial EASI score and VAS score as the main evaluation indicators to observe the safety, applicability and effectiveness of the medical skin repair patch in the adjuvant treatment of dermatitis diseases. The results showed that on the 7th and 14th days of treatment, the mean EASI and VAS values were significantly decreased compared with the baseline. At the end of the treatment (the 14th day), the mean decrease rate of EASI was 80.28%, and the mean decrease rate of VAS was 87.17%. The efficiency is 98.33%. |
| priorityDate | 2020-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.